Navigation Links
Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences

PLEASANTON, Calif., Dec. 15, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has officially notified Pacific Bioscience (PacBio) of its intention to terminate its agreement and efforts to develop a sequencing instrument for use in the clinical research and clinical market using their Single Molecule, Real-Time (SMRT®) technology.

With this termination, Roche no longer retains rights to this technology and PacBio is free to approach any market segments with their SMRT technology.

"As a result of this decision we will have greater focus on our internal development efforts and drive our long term strategy which is to be a leader in clinical diagnostic sequencing," said Neil Gunn, Head of Roche Sequencing Solutions.  "We are continuing to actively pursue multiple technologies and commercial strategies internally and externally to ensure we address the specific needs of our customers in the clinical diagnostic sequencing market segment."

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2015 employed more than 91,700 people worldwide. In 2015, Roche invested CHF 9.3 billion in R&D and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit *All trademarks used or mentioned in this release are protected by law. 

For further information, please contact:

Roche Sequencing Solutions
Elizabeth Baxter
Corporate Communications
Mobile: 925.523.8812


To view the original version on PR Newswire, visit:

Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. Atomic Force Microscope Leader Park Systems Presents Webinar on Electrochemical Scanned Probes June 16, 2016
2. Say it with Pictures: SPIE Donates Photonics Infographics Books to Rochester Science Museum
3. Roche launches new chromogen for cancer research
4. OHAUS Corporation Unveils New Laboratory Balances and Electrochemistry Meters At Pittcon 2016
5. Atomic Force Microscope Leader Park Systems Presents Electrochemistry Webinar
6. BD Boston Conference Hosted by BD Heads of Shire, Merck, Sanofi, Roche, Biogen, Teva, Nestle, AbbVie on March 9th
7. Cellular Dynamics Announces Collaboration with Roche
8. Global Biologic Therapeutics Market 2015-2019 Key Vendors are Amgen, F. Hoffmann-La Roche, Novo Nordisk & Sanofi
9. Genetic Testing Market Outlook 2015-2020: Key Vendors Influencing the Industry Include Abbott, Roche, Siemens, Illumina, Thermo Fischer Scientific, and Myriad Genetics
10. Roche strengthens oncology translational research pipeline by acquiring CAPP Medical
11. Global HER-2 Positive Breast Cancer Market 2015-2019 - Key Players are Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:6/23/2017)... N.Y. , June 23, 2017  IBM (NYSE: ... dairy research, today announced a new collaboration using next-generation ... chances that the global milk supply is impacted by ... Cornell University has become the newest academic institution to ... a food safety initiative that includes IBM Research, Mars, ...
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
Breaking Biology News(10 mins):